Every material Form 8-K Concentrix has filed with the SEC since March 26, 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Concentrix Corporation announced that Chinnu Susan Varghese will succeed Andre Valentine as Chief Financial Officer effective December 1, 2026. Mr. Valentine will remain in the role in the near term and stay through the second quarter of fiscal 2027 to support the transition.
Chinnu Susan Varghese joins Concentrix on November 9, 2026 and becomes CFO on December 1, 2026.
Andre Valentine stays on as CFO in the near term and is expected to remain with the company through the second quarter of fiscal 2027.
Ms. Varghese previously was Senior Vice President and Group Controller at Marelli and CFO, Global Growth Markets at Cognizant.
Concentrix reported fiscal third-quarter 2026 revenue of $2,453.7 million, down 1.2% from a year earlier, and a GAAP net loss of $988.1 million, or $(16.24) per diluted share, driven by a non-cash $1,050.0 million goodwill impairment. Excluding non-GAAP items, diluted EPS rose 5.0% to $2.92, and the company raised its quarterly dividend to $0.37 per share. The company guided fourth-quarter non-GAAP diluted EPS to $2.86 to $2.98 and full-year 2026 non-GAAP diluted EPS to $10.97 to $11.09.
Revenue was $2,453.7 million, down 1.2% as reported and down 0.5% in constant currency
GAAP operating loss of $(910.3) million and net loss of $(988.1) million include a $1,050.0 million goodwill impairment
Non-GAAP operating income rose 1.3% to $309.0 million and non-GAAP net income rose 1.8% to $186.5 million
Quarterly dividend raised to $0.37 from $0.36, payable November 3, 2026; no shares repurchased in the quarter, with $396.6 million authorization remaining
Concentrix said its Executive Vice President of Customer Success, Cormac Twomey, will step down effective December 31, 2026, under an agreement dated September 15, 2026. He will provide transition support as a consultant for 60 days after leaving, and his severance follows the company's executive severance plan and his UK service agreement. The filing does not describe financial effects, and the change affects one senior executive role.
Cormac Twomey, Executive Vice President, Customer Success, will step down effective December 31, 2026
Agreement with Twomey dated September 15, 2026 provides severance under the Amended and Restated Executive Severance Plan and his 2019 UK service agreement
Twomey will serve as a consultant for limited transition support for a 60-day period after separation
On July 23, 2026, Concentrix's Board adopted an Amended and Restated Executive Severance Plan that replaces its Change of Control Severance Plan, following an annual compensation review. The amended plan raises severance for executives terminated without cause within two months before or 12 months after a change of control, and adds severance for such terminations outside that window.
Plan adopted July 23, 2026, replacing the Change of Control Severance Plan.
Change-of-control severance changes from salary continuation of 18 to 24 months to two times base salary plus target bonus, less withholding.
New severance of base salary plus target bonus, less withholding, applies to terminations outside the change-of-control window.
Plan adds a 'best-net' Section 280G cut-back provision; full plan filed as Exhibit 10.1.
Concentrix reported fiscal second-quarter 2026 results for the period ended May 31, 2026, with revenue up 1.9% to $2.46 billion, but operating income fell 35.7% to $95.4 million and non-GAAP diluted EPS fell 2.6% to $2.63. The company guided to non-GAAP diluted EPS of $10.83 to $11.18 for the full fiscal year, and expects adjusted free cash flow of $630 million to $650 million, while reporting no share repurchases in the quarter.
Revenue was $2,462.5 million, up 1.9% as reported and 0.6% in constant currency, versus $2,417.4 million a year earlier.
GAAP diluted EPS was $0.86, up from $0.63, while non-GAAP diluted EPS was $2.63, down from $2.70; non-GAAP operating income was $292.0 million, down 3.9%.
Acquisition-related, integration and restructuring expenses were $65.5 million in the quarter, versus $16.8 million a year earlier.
Third-quarter non-GAAP diluted EPS is expected at $2.65 to $2.77; the quarterly dividend of $0.36 per share is payable August 4, 2026.
Concentrix director Bilge Ogut resigned from the board effective immediately after GBL, the former parent of the Webhelp business, reduced its Concentrix holdings below a 50% threshold that had entitled it to nominate a director. The filing reflects a contractual board-seat change tied to GBL's ownership and does not report any change to company financial results.
Bilge Ogut resigned from the Board and all committees, effective immediately.
The resignation followed a GBL transaction on April 29, 2026 that reduced its holdings below the Board Nomination Threshold.
The threshold was 50% of shares issued to GBL in connection with the September 2023 Webhelp acquisition.
The filing was dated May 1, 2026 and signed by Jane C. Fogarty, Executive Vice President, Legal.
At its annual meeting on March 25, 2026, Concentrix stockholders approved an amendment adding 3,700,000 shares to the 2020 Stock Incentive Plan, and elected all nine nominated directors. The plan amendment drew 15,803,365 votes against, a notable level of opposition, though it passed.
Stockholders approved adding 3,700,000 shares to the 2020 Plan on March 25, 2026; the Board had previously approved the amendment.
Plan amendment vote: 36,462,977 for, 15,803,365 against, 46,819 abstain, 4,290,089 broker non-votes.
All nine directors were elected for terms expiring at the 2027 annual meeting; Christopher Caldwell received 51,981,955 votes for.
Ernst & Young LLP was ratified as independent registered accounting firm for fiscal 2026 with 56,049,937 votes for and 453,129 against.
Concentrix reported first quarter fiscal 2026 results for the period ended February 28, 2026. Revenue rose 5.4% to $2.5 billion, but net income fell 69% to $21.6 million and diluted EPS fell to $0.33 from $1.04, while non-GAAP diluted EPS fell 6.5% to $2.61. The company also gave second quarter and full year 2026 guidance, with full year non-GAAP diluted EPS expected at $11.48 to $12.07.
Revenue was $2,500.4 million, up 5.4% as reported and 1.9% in constant currency; operating income fell 29.8% to $118.6 million.
Non-GAAP operating income was $295.0 million, down 8.2%, and non-GAAP operating margin fell to 11.8% from 13.6%.
Second quarter revenue is expected at $2.460 billion to $2.485 billion, with non-GAAP diluted EPS of $2.57 to $2.69.
Full year 2026 reported revenue is expected at $10.035 billion to $10.180 billion, and adjusted free cash flow at $630.0 million to $650.0 million.
Concentrix amended its accounts receivable securitization facility on March 20, 2026, with PNC Bank as administrative agent. The amendment raises available lender commitments from up to $700 million to up to $750 million and extends the termination date from January 14, 2027 to March 20, 2028. The filing describes a routine financing update that increases borrowing capacity and pushes out the facility's maturity.
Lender commitments increased from up to $700 million to up to $750 million
Termination date extended from January 14, 2027 to March 20, 2028
Amendment dated March 20, 2026; Concentrix Receivables, Inc. is the borrower and Concentrix is servicer
PNC Bank, National Association serves as administrative agent
Concentrix issued and sold $600 million of 6.500% Senior Notes due March 1, 2029, in a registered public offering on February 24, 2026. The company said it used the proceeds with other available funds to redeem $600 million of its 6.650% Senior Notes due August 2, 2026, which had $800 million outstanding before the redemption. The filing describes a refinancing of existing debt; it does not state a change in total borrowing.
Notes carry a 6.500% rate, paid semi-annually from September 1, 2026, maturing March 1, 2029
Proceeds plus other funds used to redeem $600 million of 6.650% notes due August 2, 2026, with $800 million previously outstanding
Rate can adjust if Moody's, S&P or Fitch downgrade or later upgrade the notes' rating
Notes are redeemable before February 1, 2029 at the greater of par or a make-whole price
Concentrix reported fourth-quarter and fiscal 2025 results (ended November 30, 2025) with revenue up 4.3% in the quarter and 2.2% for the year. A non-cash goodwill impairment charge of $1,523.3 million produced a fourth-quarter diluted loss of $23.85 per share and a fiscal-year net loss of $1,278.9 million, while non-GAAP diluted EPS fell 9.5% in the quarter. The company also issued fiscal 2026 guidance calling for revenue of $10.035 billion to $10.180 billion and non-GAAP diluted EPS of $11.48 to $12.07.
Q4 revenue was $2,552.9 million, up 4.3% year-on-year; non-GAAP diluted EPS was $2.95 versus $3.26 a year earlier
Fiscal 2025 diluted loss per share was $(20.36) including the $1,523.3 million goodwill impairment, compared with $3.71 of diluted EPS in fiscal 2024
Fiscal 2026 guidance: reported revenue of $10.035 billion to $10.180 billion; non-GAAP diluted EPS of $11.48 to $12.07; adjusted free cash flow of $630 million to $650 million
Quarterly dividend of $0.36 per share declared, payable February 10, 2026, to holders of record on January 30, 2026
Concentrix reported fiscal third-quarter 2025 results for the period ended August 31, 2025, with revenue up 4.0% to $2.48 billion and GAAP net income rising to $88.1 million from $16.6 million. Non-GAAP operating income and non-GAAP diluted EPS both declined year-on-year, while the company raised its full-year constant currency revenue growth outlook and increased its quarterly dividend. For shareholders, the top line and GAAP profit improved, but the company's adjusted profit measures fell.
Revenue of $2.48 billion, up 4.0% year-on-year (2.6% on a constant currency basis), exceeding the company's guidance for the quarter.
Non-GAAP diluted EPS of $2.78 vs. $2.87 a year earlier, down 3.1%; GAAP diluted EPS of $1.34 vs. $0.25.
Full-year fiscal 2025 constant currency revenue growth outlook raised to 1.75% to 2.0%; fourth-quarter reported revenue expected at $2.525 billion to $2.550 billion.
Quarterly dividend increased to $0.36 per share from $0.33275, payable November 4, 2025.
Concentrix reported fiscal second-quarter 2025 revenue of $2,417.4 million, up 1.5% from a year earlier, and raised its full-year constant currency revenue growth outlook to 1.0% to 2.0%. GAAP diluted EPS fell 35.7% to $0.63, while non-GAAP diluted EPS was $2.70 versus $2.69, and management cited mid-quarter program pauses and investments as reasons non-GAAP operating income declined 5.4%.
Q2 revenue of $2,417.4 million, up 1.5% year-on-year; GAAP operating income of $148.3 million, down 1.3%
GAAP diluted EPS of $0.63 versus $0.98; non-GAAP diluted EPS of $2.70 versus $2.69
Full-year 2025 reported revenue guidance of $9.720 billion to $9.815 billion; non-GAAP EPS guidance of $11.53 to $11.76
Adjusted free cash flow of $200.3 million in the quarter; company expects $625 million to $650 million for fiscal 2025 and about $240 million returned to shareholders
Concentrix director Olivier Duha notified the board on June 3, 2025 that he is resigning, effective immediately, including from all board committees. The company said the resignation was for personal reasons and not due to any disagreement over operations, policies or practices.
Resignation notified to the board on June 3, 2025; effective immediately
Duha also leaves all board committees
Company states the resignation was for personal reasons, not a disagreement with the company
Concentrix entered into an Amendment and Restatement Agreement on April 11, 2025, with Bank of America, N.A. taking over as administrative agent from JPMorgan Chase Bank, N.A. The restated credit agreement provides a $1.1 billion revolving facility, a $750 million unsecured term loan, and up to $750 million of delayed draw term loans, and the company also amended its receivables securitization facility. For shareholders, the filing sets new debt terms and maturities, and the company intends to use the delayed draw loans to repay a €700 million promissory note issued for the Webhelp combination.
Revolving credit facility of up to $1.1 billion, maturing April 11, 2030
New $750 million three-year term loan, with $250 million three-year and $500 million five-year delayed draw term loans that must be funded by September 30, 2025
Delayed draw loan proceeds intended to repay in full a €700 million promissory note issued to sellers in the September 2023 Webhelp combination
Financial covenants require a consolidated leverage ratio of no more than 3.75 to 1.00 and an interest coverage ratio of at least 3.00 to 1.00
Concentrix reported first-quarter fiscal 2025 results for the period ended February 28, 2025. Revenue fell 1.3% from a year earlier to $2.37 billion, while GAAP diluted earnings per share rose 36.8% to $1.04 and non-GAAP diluted EPS rose 8.6% to $2.79. The company reiterated its full-year fiscal 2025 guidance and gave second-quarter outlook figures.
Q1 revenue of $2,372.2 million, down 1.3% year-on-year as reported and up 1.3% in constant currency
GAAP diluted EPS of $1.04 versus $0.76; non-GAAP diluted EPS of $2.79 versus $2.57
Adjusted free cash flow was a use of $39.8 million in the quarter; full-year adjusted free cash flow expected at $625 million to $650 million
Second-quarter non-GAAP EPS expected at $2.69 to $2.80; full-year fiscal 2025 reported revenue expected at $9.490 billion to $9.635 billion
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Concentrix filing is on SEC EDGAR ↗. 8-K briefs of other companies →